INC Research/inVentiv Health to Present at Upcoming J.P. Morgan Healthcare Conference Nasdaq:INCR

(MENAFNEditorial) RALEIGH, N.C., Dec. 14, 2017 (GLOBE NEWSWIRE) -- INC Research/inVentiv Health (Nasdaq:), the only fully integrated biopharmaceutical solutions organization, today announced that Chief Executive Officer Alistair Macdonald is scheduled to present at the 36th Annual J.P. Morgan Healthcare Conference in San Francisco. Mr. Macdonald's presentation is scheduled for Tuesday, January 9, 2018, at 8:00 a.m. PST.

Links to INC/inVentiv's live presentation and archived audio replay, as well as the presentation materials, will be available via the Company's Investor Relations website at .

About INC Research/inVentiv Health
INC Research/inVentiv Health (Nasdaq:) is the only fully integrated biopharmaceutical solutions organization. Our company, including a Contract Research Organization (CRO) and Contract Commercial Organization (CCO), is purpose-built to address new market realities where clinical and commercial share expertise, data and insights to accelerate biopharmaceutical performance. With more than 22,000 employees and the ability to support customers in more than 110 countries, our global scale and deep therapeutic alignment enables INC Research/inVentiv Health to help customers successfully navigate an increasingly complex environment. For more information on our Raleigh, N.C.-based company, visit or .

Investor Relations Contact: Press/Media Contact: Ronnie Speight Danielle DeForge Vice President, Investor Relations Senior Director, External Communications +1 919 745 2745 +1 781 425 2624

MENAFN1412201700703653ID1096235685